Harvard Bioscience (United States)
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company has 12 wholly owned subsidiaries. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Harvard Bioscience (United States), United States, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
86%
Total
Publications
110
Total Open
Publications
95
Total
Citations
6.7K
Open Access
Percentage
86%
Total
Publications
110
Total Open
Publications
95
Total
Citations
6.7K
Breakdown
Publisher Open
11%
Both
43%
Other Platform Open
33%
Closed
13%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
18
Hybrid 46%
27
No Guarantees 24%
14
Other Platform Open
Domain 67%
56
Preprint 28%
23
Institution 24%
20
Other Internet 23%
19
Public 8%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 56 |
Europe PMC | Domain | 38 |
DOI | Other Internet | 36 |
bioRxiv | Preprint | 21 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 8 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 6 |
Massachusetts Institute of Technology - DSpace@MIT | Institution | 5 |
Semantic Scholar | Public | 4 |
Figshare | Public | 4 |
CiteSeer X | Other Internet | 4 |